Phase 3 Readout~month

Phase 3 Topline: A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous I

Drug
dbv712
Indication
Allergy; Peanut Allergy

Other upcoming events for DBVT

Phase 3 ReadoutPhase 3 Topline: An Open-label, Single Arm Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of L
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Double-blind, Placebo-controlled, Randomized Study to Assess the Efficacy and Safety of E

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 3, Double-Blind, Placebo-Controlled, Randomized Study to Assess the Safety of Epicutaneous I — DBVT Phase 3 Readout | BioSniper